<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03725748</url>
  </required_header>
  <id_info>
    <org_study_id>assistant professor2</org_study_id>
    <nct_id>NCT03725748</nct_id>
  </id_info>
  <brief_title>Normal Saline Versus Betadine Use to Reduce the Incidence of Wound Infection in Cesarean Section</brief_title>
  <official_title>Normal Saline Versus Betadine Use to Reduce the Incidence of Wound Infection in Cesarean</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kasr El Aini Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective randomized controlled study to the difference between using normal
      saline or betadine irrigation of wound prior to skin closure in reducing the incidence of
      wound infection after Cesarean section.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be conducted at the Department of Obstetrics &amp; Gynecology, Kasr El-Ainy
      Teaching Hospital, Faculty of Medicine, Cairo University, from February to July 2018.

      We include in our study 3oo pregnant women who will undergo Cesarean section. All
      participants will be divided into 3 groups with a 1:1:1 ratio with 100 patients in each
      group. Each participant will provide an informed written consent.

      Consenting patients will be pre-operatively randomised using numerically ordered cards in
      sealed envelopes to either the group 1 (wound irrigation with 100 ml of normal saline before
      skin closure) or the group 2 (wound irrigation with 50 ml of 10% aqueous povidone iodine
      solution ̋ Betadinȅ ) or the control group (no wound irrigation with normal saline nor
      betadine).Subjects candidate for the study will be 37 weeks' gestation and require a cesarean
      section (elective or emergency). Patients with allergy to iodine, history of
      immunosuppressive drug use, gestationaldiabetes mellitus or preeclampsia, anemic patients,
      ruptured of membranes and feverish patients will be excluded from the study.

      The primary outcome will be the incidence of wound infection. Wound infection is diagnosed
      when the wound drained purulent material or serosanguineous fluid in association with
      induration, warmth and tenderness. Suspected wound infections are opened for confirmation and
      wound cultures will be taken. Haematoma, seroma, or wound breakdown in the absence of the
      previouslydiscussed signs is not considered a wound infection.Wounds are examined twice daily
      during hospitalization for evidence of infection. After discharge, the women are instructed
      on the signs and symptoms of wound infection, and asked to contact one of the co-authors
      immediately if any of the listed symptoms appeared. All participants are examined at 2 and 6
      weeks after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2018</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of cs scar infection</measure>
    <time_frame>2 to 6 weeks</time_frame>
    <description>incidence of cs scar infection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of hematoma, seroma</measure>
    <time_frame>2 to 6 weeks</time_frame>
    <description>incidence of hematoma, seroma, wound breakdown</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Incidence of cs Scar Infection</condition>
  <arm_group>
    <arm_group_label>no irrigation group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>nothing used for irrigation of cs scar</description>
  </arm_group>
  <arm_group>
    <arm_group_label>saline irrigation group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>saline used for irrigation the cs scar before closure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>betadine irrigation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>betadine used for irrigation of cs scar</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>irrigation</intervention_name>
    <description>irrigation the edges of the cs scar before closure</description>
    <arm_group_label>betadine irrigation group</arm_group_label>
    <arm_group_label>saline irrigation group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects candidate for the study will be 37 weeks' gestation

          -  require a cesarean section (elective or emergency).

        Exclusion Criteria:

          -  Patients with allergy to iodine

          -  history of immunosuppressive drug use,

          -  gestationaldiabetes mellitus

          -  preeclampsia

          -  anemic patients

          -  ruptured of membranes

          -  feverish patients
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>37 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>fady salah, lecturer</last_name>
    <role>Study Director</role>
    <affiliation>director</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>hany saad, assistant prof</last_name>
    <phone>01001817211</phone>
    <email>dr_hanysaad@yahoo.co.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ashraf saad, lecturer</last_name>
    <phone>01001817221</phone>
    <email>ashraf@yahoo.co.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kasr El Ainy</name>
      <address>
        <city>Cairo</city>
        <zip>02</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>mohamed saad, lecturer</last_name>
      <phone>01244336666</phone>
      <email>msaad@scimitar.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 20, 2018</study_first_submitted>
  <study_first_submitted_qc>October 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2018</study_first_posted>
  <last_update_submitted>October 29, 2018</last_update_submitted>
  <last_update_submitted_qc>October 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>hadeer meshal</investigator_full_name>
    <investigator_title>assistant prfessor</investigator_title>
  </responsible_party>
  <keyword>saline, betadine, cesarean scar infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Wound Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

